ISOVUE-M 612 mg/mL (Iopamidol INJECTION, SOLUTION) 612 mg/mL

ISOVUE-M 612 mg/mL is an injectable solution containing iopamidol, used for diagnostic imaging procedures. This contrast agent aids in enhancing visibility during medical imaging, ensuring clear and accurate results.

Strength

612 mg/mL

Pack Size

10 VIAL, SINGLE-DOSE in 1 PACKAGE (0270-1412-15) / 15 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ISOVUE-M 612 mg/mL is primarily used as a contrast medium for diagnostic imaging. It helps improve the visibility of internal structures during procedures such as computed tomography (CT) scans and other imaging techniques. This solution is often utilized in medical settings to assist healthcare professionals in obtaining detailed images for better diagnosis and treatment planning.

Side Effects

When administered, ISOVUE-M 612 mg/mL works by temporarily altering the way certain tissues and structures appear on imaging scans. This enhancement allows for clearer visualization, which can be crucial for identifying abnormalities or areas of concern. The effects are typically short-lived and specific to the imaging procedure.

Precautions & Warnings

ISOVUE-M 612 mg/mL should be handled with care and administered by trained healthcare professionals. It is important to follow proper protocols to ensure safety and effectiveness. Patients with known allergies to contrast agents or iodine should inform their healthcare provider before use.

Avoid Interactions

ISOVUE-M 612 mg/mL may interact with certain medications or conditions. It is important to discuss any current medications or health conditions with a healthcare provider before administration. Specific interactions can vary, so professional guidance is recommended.

Frequently Asked Questions

ISOVUE-M 612 mg/mL is used as a contrast agent for diagnostic imaging procedures, enhancing the visibility of internal structures during scans.

ISOVUE-M 612 mg/mL is administered as an injection by healthcare professionals during imaging procedures.

The common effects include temporary enhancement of visibility in imaging scans, aiding in the identification of internal structures.

Yes, it should be administered by trained professionals, and patients with allergies to contrast agents or iodine should inform their healthcare provider.

Potential interactions can occur, so it is important to discuss current medications with a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.